Cardiometabolic Medicine

The need for consistent updates and agile content is imperative for today’s clinician to remain current on the continuum of scientific data. In no therapeutic area is this more essential than in “Cardiometabolic Medicine,” a new term meant to encompass the interconnected and debilitating diagnoses of diabetes mellitus, heart failure, coronary artery disease/acute coronary syndrome, progressive renal insufficiency, and related disorders such as hypertension, hyperlipidemia, and hyperkalemia.  These areas are subject to frequent pivotal trial publications, guidelines updates, FDA action, and outcomes assessments.  

Our Tweetorials

Your new source for free CE/CME via Twitter!
Each program provides 0.5h credit for physicians, pharmacists, and nurses.

Introduction to NAFLD/NASH

Be sure to join here TOMORROW for our FIRST @cardiomet_CE accredited #tweetorial on non-alcoholic fatty #liver disease (#NAFLD) / non-alcoholic...

@Cardiomet_CE on Twitter

Your only source for ACCREDITED SoMe-delivered 

serialized professional cardiometabolic education. Physicians, nurses, pharmacists–come one, come all!

On Twitter at @cardiomet_ce, we present a series of tweetorials, Twitter-delivered case studies, and Twitter Journal Clubs, each accredited for 0.5hr CE/CME.  Programs are presented by expert faculty in engaging and fully interactive format.  Our unique program harnesses the reach, up-to-the-minute currency, and accessibility of social media to deliver a constant flow of accredited, interactive, expert-delivered educational programs to a multidisciplinary and interprofessional audience of engaged clinicians.

Completed programs appear “unrolled” on this webpage, but to maximize the learning value of these innovative programs, please follow @cardiomet_ce.

For those of you who missed it last week here are my updated @GPnotebook prescribing tools for prescribing in T2D & renal impairment and also extra-glycaemic indications of SGLT2 inhibitors

PDF download at

All feedback welcome!


Load More...